BERKELEY, Calif. — December 30, 2025 — Leads & Copy —
Profusa, Inc. (Nasdaq: PFSA) has announced the restructuring of its Senior Secured Convertible Note to provide greater repayment flexibility and reduce potential dilution.
The amended notes feature an increase in the conversion floor price to $0.35, up from the previous $0.10. Additionally, mandatory cash and equity amortization payments have been eliminated, contrasting with the original schedule that was set to begin in the first quarter of 2026. The final payment is due at the notes’ maturity, 18 months after each specific note’s issuance.
Mandatory payments related to the ELOC (equity line of credit) have also increased. They now stand at 33% for shares issued under the existing registration statement and will rise to 50% for shares issued under any registration statement on Form S-1 filed after the date of the announcement.
Fred Knechtel, CFO of Profusa, stated that the restructuring is part of the company’s balance sheet recapitalization efforts. He emphasized that these changes aim to reduce debt and share price dilution, ultimately providing shareholders with additional value as the company’s enterprise value increases.
Dr. Ben Hwang, Chairman and CEO of Profusa, expressed enthusiasm about the company’s progress toward revenue generation and balance sheet restructuring. He affirmed the company’s commitment to delivering long-term value to its shareholders. The increased flexibility in note repayment will allow Profusa to focus resources on accelerating initiatives, developing partnerships, and supporting inventory build in the first quarter of 2026.
Profusa, based in Berkeley, California, is a commercial-stage digital health company focused on developing tissue-integrated sensors. These sensors are designed to continuously transmit actionable, medical-grade data for personal and medical applications. The company’s technology aims to provide individuals with a personalized biochemical signature, offering clinicians reliable data.
“LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa Inc.
Investor and Media Contacts:
email: info@coreir.com
phone: 1 (212) 655-0924
Source: Profusa
